Articles dans des revues avec comité de lecture (144)
  1. 21. Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V. V., Mallon, P. P., Marcello, A., Van Lint, C., Rohr, O., & Schwartz, C. (2019). Microglial Cells: The Main HIV-1 Reservoir in the Brain. Frontiers in Cellular and Infection Microbiology, 9, 362. doi:10.3389/fcimb.2019.00362
  2. 22. Verdikt, R., Darcis, G., Aït-Ammar, A., & Van Lint, C. (2019). Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence. Current opinion in virology, 38, 63-69. doi:10.1016/j.coviro.2019.07.004
  3. 23. Malu, A., Hutchison, T., Yapindi, L., Smith, K., Nelson, K., Bergeson, R., Pope, J., Romeo, M., Harrod, C. K., Ratner, L., Van Lint, C., & Harrod, R. (2019). The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-kB p65RelA-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability. Virology, 535, 83-101. doi:10.1016/j.virol.2019.07.003
  4. 24. Turrini, F., Saliu, F., Forlani, G., Das, A. A., Van Lint, C., Accolla, R. R., Berkhout, B., Poli, G., & Vicenzi, E. (2019). Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines. Virus research, 269, 197631. doi:10.1016/j.virusres.2019.05.009
  5. 25. Bouchat, S., & Van Lint, C. (2019). [Viral latency of HIV-1]. Virologie, 23(4), 195-210. doi:10.1684/vir.2019.0782
  6. 26. Kula, A., Delacourt, N., Bouchat, S., Darcis, G., Avettand-Fenoel, V., Verdikt, R., Corazza, F., Necsoi, C. V., Vanhulle, C., Bendoumou, M., Burny, A., De Wit, S., Rouzioux, C., Rohr, O., & Van Lint, C. (2019). Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments. Journal of acquired immune deficiency syndromes, 80(5), 605-613. doi:10.1097/QAI.0000000000001958
  7. 27. Van Lint, C. (2018). Stop HUSHing on SIV/HIV. Nature Microbiology, 3(12), 1336-1338. doi:10.1038/s41564-018-0308-2
  8. 28. Sarracino, A., Gharu, L., Kula, A., Pasternak, A., Avettand-Fenoel, V., Rouzioux, C., Bardina, M., De Wit, S., Benkirane, M., Berkhout, B., Van Lint, C., & Marcello, A. (2018). Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. MBio, 9(6). doi:10.1128/mBio.02158-18
  9. 29. Collignon, E., Canale, A., Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., Bouchat, S., Hubert, P., Van Lint, C., Yull, F., Sotiriou, C., Willard-Gallo, K., Noël, A., & Fuks, F. (2018). Immunity drives TET1 regulation in cancer through NF-kB. Science advances, 4(6), eaap7309. doi:10.1126/sciadv.aap7309
  10. 30. El Khoury, G., Darcis, G., Lee,, Bouchat, S., Van Driessche, B., Purcell, D., & Van Lint, C. (2018). The Molecular Biology of HIV Latency. Advances in experimental medicine and biology, 1075, 187-212. doi:10.1007/978-981-13-0484-2_8
  11. 31. Darcis, G., Van Driessche, B., Bouchat, S., Kirchhoff, F., & Van Lint, C. (2017). Molecular Control of HIV and SIV Latency. Current topics in microbiology and immunology. doi:10.1007/82_2017_74
  12. 32. Fauquenoy, S., Robette, G., Kula, A., Vanhulle, C., Bouchat, S., Delacourt, N., Rodari, A., Marban, C., Schwartz, C., Burny, A., Rohr, O., Van Driessche, B., & Van Lint, C. (2017). Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites. Scientific reports, 7, 43221. doi:10.1038/srep43221
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>